Type I interferon signals control Theiler's virus infection site, cellular infiltration and T cell stimulation in the CNS

Journal of Neuroimmunology

Volumn 226, Issue 1-2, 2010, Pages 27-37

  Jin, Young Hee ^a   Hou, Wanqiu ^a   Kim, Seung Jae ^a   Fuller, Alyson C ^a   Kang, Bongsu ^a   Goings, Gwen ^a   Miller, Stephen D ^a   Kim, Byung S ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

CNS infiltration; Co stimulatory molecules; T cell responses; TMEV; Type I IFNs

Indexed keywords

GAMMA INTERFERON; INTERFERON; INTERFERON RECEPTOR; INTERLEUKIN 17; ALPHA BETA INTERFERON RECEPTOR; CYTOKINE; IFNAR1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE SEVERITY; ENCEPHALITIS; FATALITY; KNOCKOUT MOUSE; LYMPHOCYTE COUNT; MOUSE; MURINE ENCEPHALOMYELITIS VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; VIRUS LOAD; WILD TYPE; ANIMAL; ANTIGEN PRESENTING CELL; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; DEFICIENCY; DRUG EFFECTS; ENTEROVIRUS INFECTION; FEMALE; FLOW CYTOMETRY; IMMUNOLOGY; METABOLISM; NEUTROPHIL CHEMOTAXIS; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; PROCEDURES; SIGNAL TRANSDUCTION; T LYMPHOCYTE; VIROLOGY;

ANIMALS; ANTIGEN-PRESENTING CELLS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; CYTOKINES; ENTEROVIRUS INFECTIONS; FEMALE; FLOW CYTOMETRY; INTERFERON TYPE I; INTERLEUKIN-17; MICE; MICE, KNOCKOUT; NEUTROPHIL INFILTRATION; RECEPTOR, INTERFERON ALPHA-BETA; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; THEILOVIRUS;

EID: 77956341484     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2010.05.028     Document Type: Article

References (47)

1. Biron C.A. Interferons alpha and beta as immune regulators-a new look. Immunity 2001, 14:661-664.
2. Biron C.A., Nguyen K.B., et al. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 1999, 17:189-220.
3. Brinkmann V., Geiger T., et al. Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells. J. Exp. Med. 1993, 178:1655-1663.
4. Curtsinger J.M., Valenzuela J.O., et al. Type I IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation. J. Immunol. 2005, 174:4465-4469.
5. Delhaye S., Paul S., et al. Neurons produce type I interferon during viral encephalitis. Proc Natl Acad Sci U S A 2006, 103:7835-7840.
6. Dunn G.P., Bruce A.T., et al. A critical function for type I interferons in cancer immunoediting. Nat. Immunol. 2005, 6:722-729.
7. Fiette L., Aubert C., et al. Theiler's virus infection of 129Sv mice that lack the interferon alpha/beta or interferon gamma receptors. J. Exp. Med. 1995, 181:2069-2076.
8. Frasca L., Fedele G., et al. CD38 orchestrates migration, survival, and Th1 immune response of human mature dendritic cells. Blood 2006, 107:2392-2399.
9. Gallucci S., Lolkema M., et al. Natural adjuvants: endogenous activators of dendritic cells. Nat. Med. 1999, 5:1249-1255.
10. Garcia-Sastre A., Biron C.A. Type 1 interferons and the virus-host relationship: a lesson in detente. Science 2006, 312:879-882.
11. Goodin D.S. Interferon-beta therapy in multiple sclerosis: evidence for a clinically relevant dose response. Drugs 2001, 61:1693-1703.
12. Grayson M.H., Ramos M.S., et al. Controls for lung dendritic cell maturation and migration during respiratory viral infection. J. Immunol. 2007, 179:1438-1448.
13. Havenar-Daughton C., Kolumam G.A., et al. Cutting edge: the direct action of type I IFN on CD4 T cells is critical for sustaining clonal expansion in response to a viral but not a bacterial infection. J. Immunol. 2006, 176:3315-3319.
14. Hou W., So E.Y., et al. Role of dendritic cells in differential susceptibility to viral demyelinating disease. PLoS Pathog. 2007, 3:e124.
15. Inoue A., Choe Y.K., et al. Analysis of antibody responses to predominant linear epitopes of Theiler's murine encephalomyelitis virus. J. Virol. 1994, 68:3324-3333.
16. Ireland D.D., Stohlman S.A., et al. Type I interferons are essential in controlling neurotropic coronavirus infection irrespective of functional CD8 T cells. J. Virol. 2008, 82:300-310.
17. Isaacs A., Lindenmann J. Virus interference. I. The interferon. Proc. R. Soc. Lond. B Biol. Sci. 1957, 147:258-267.
18. Jin Y.H., Mohindru M., et al. Differential virus replication, cytokine production, and antigen-presenting function by microglia from susceptible and resistant mice infected with Theiler's virus. J. Virol. 2007, 81:11690-11702.
19. Kang M.H., So E.Y., et al. Replication of Theiler's virus requires NF-kappaB-activation: higher viral replication and spreading in astrocytes from susceptible mice. Glia 2008, 56:942-953.
20. Kim B.S., Palma J.P., et al. Pathogenic immunity in Theiler's virus-induced demyelinating disease: a viral model for multiple sclerosis. Arch. Immunol. Ther. Exp. 2000, 48:373-379.
21. Kolumam G.A., Thomas S., et al. Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J. Exp. Med. 2005, 202:637-650.
22. Lee C.K., Rao D.T., et al. Distinct requirements for IFNs and STAT1 in NK cell function. J. Immunol. 2000, 165:3571-3577.
23. Mohindru M., Kang B., et al. Initial capsid-specific CD4(+) T cell responses protect against Theiler's murine encephalomyelitisvirus-induced demyelinating disease. Eur. J. Immunol. 2006, 36:2106-2115.
24. Montoya M., Schiavoni G., et al. Type I interferons produced by dendritic cells promote their phenotypic and functional activation. Blood 2002, 99:3263-3271.
25. Muller U., Steinhoff U., et al. Functional role of type I and type II interferons in antiviral defense. Science 1994, 264:1918-1921.
26. Nguyen K.B., Salazar-Mather T.P., et al. Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection. J. Immunol. 2002, 169:4279-4287.
27. Niemela J., Ifergan I., et al. IFN-beta regulates CD73 and adenosine expression at the blood-brain barrier. Eur. J. Immunol. 2008, 38:2718-2726.
28. Njenga M.K., Coenen M.J., et al. Short-term treatment with interferon-alpha/beta promotes remyelination, whereas long-term treatment aggravates demyelination in a murine model of multiple sclerosis. J. Neurosci. Res. 2000, 59:661-670.
29. Palma J.P., Kwon D., et al. Infection with Theiler's murine encephalomyelitis virus directly induces proinflammatory cytokines in primary astrocytes via NF-kappaB activation: potential role for the initiation of demyelinating disease. J. Virol. 2003, 77:6322-6331.
30. Pestka S., Krause C.D., et al. Interferons, interferon-like cytokines, and their receptors. Immunol. Rev. 2004, 202:8-32.
31. Prinz M., Schmidt H., et al. Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system. Immunity 2008, 28:675-686.
32. Pullen L.C., Park S.H., et al. Treatment with bacterial LPS renders genetically resistant C57BL/6 mice susceptible to Theiler's virus-induced demyelinating disease. J. Immunol. 1995, 155:4497-4503.
33. Rudick R.A., Ransohoff R.M., et al. Interferon beta induces interleukin-10 expression: relevance to multiple sclerosis. Ann. Neurol. 1996, 40:618-627.
34. Santini S.M., Lapenta C., et al. Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice. J. Exp. Med. 2000, 191:1777-1788.
35. Satoh J., Paty D.W., et al. Differential effects of beta and gamma interferons on expression of major histocompatibility complex antigens and intercellular adhesion molecule-1 in cultured fetal human astrocytes. Neurology 1995, 45:367-373.
36. Sethi P., Lipton H.L. Location and distribution of virus antigen in the central nervous system of mice persistently infected with Theiler's virus. Br. J. Exp. Pathol. 1983, 64:57-65.
37. So E.Y., Kang M.H., et al. Induction of chemokine and cytokine genes in astrocytes following infection with Theiler's murine encephalomyelitis virus is mediated by the Toll-like receptor 3. Glia 2006, 53:858-867.
38. Stone L.A., Frank J.A., et al. The effect of interferon-beta on blood-brain barrier disruptions demonstrated by contrast-enhanced magnetic resonance imaging in relapsing-remitting multiple sclerosis. Ann. Neurol. 1995, 37:611-619.
39. Takaoka A., Yanai H. Interferon signalling network in innate defence. Cell. Microbiol. 2006, 8:907-922.
40. Takaoka A., Mitani Y., et al. Cross talk between interferon-gamma and -alpha/beta signaling components in caveolar membrane domains. Science 2000, 288:2357-2360.
41. Teige I., Liu Y., et al. IFN-beta inhibits T cell activation capacity of central nervous system APCs. J. Immunol. 2006, 177:3542-3553.
42. Theiler M. Spontaneous encephalomyelitis of mice-a new virus disease. Science 1934, 80:122.
43. Theofilopoulos A.N., Baccala R., et al. Type I interferons (alpha/beta) in immunity and autoimmunity. Annu. Rev. Immunol. 2005, 23:307-336.
44. Tompkins S.M., Padilla J., et al. De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis. J. Immunol. 2002, 168:4173-4183.
45. Vermersch P., de Seze J., et al. Interferon beta1a (Avonex) treatment in multiple sclerosis: similarity of effect on progression of disability in patients with mild and moderate disability. J. Neurol. 2002, 249:184-187.
46. Wandinger K.P., Sturzebecher C.S., et al. Complex immunomodulatory effects of interferon-beta in multiple sclerosis include the upregulation of T helper 1-associated marker genes. Ann. Neurol. 2001, 50:349-357.
47. Warabi Y., Matsumoto Y., et al. Interferon beta-1b exacerbates multiple sclerosis with severe optic nerve and spinal cord demyelination. J. Neurol. Sci. 2007, 252:57-61.